Le Lézard
Classified in: Health
Subject: AVO

Statement from the President and CEO of the MHCC on the International Day of La Francophonie


OTTAWA, March 20, 2018 /CNW/ - Today is International Day of La Francophonie, and the Mental Health Commission of Canada (MHCC) is pleased to extend our warm wishes to those who are marking the occasion.

Canada's linguistic duality enriches our heritage. We are blessed to live in a country where la Francophonie is recognized and supported. However, it must be acknowledged that francophone communities living in minority situations face many daily challenges. It is important to work collaboratively to improve services in these communities.

The MHCC is exploring innovative solutions ? like our e-mental health research project and policy roundtable to expand public access to psychotherapies ? to improve timely access to culturally appropriate treatments for Canadians, no matter where they live or the language they speak.

Louise Bradley
President and CEO, Mental Health Commission of Canada

Follow MHCC on Facebook
Follow MHCC on Twitter
Follow MHCC on LinkedIn

 

SOURCE Mental Health Commission of Canada


These press releases may also interest you

at 06:05
Rocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced longer-term data updates from its lentiviral (LV)...

at 06:00
Medical Polymer Market worth $60.5 billion by 2029 - Exclusive Report by MarketsandMarketstm
The report "Medical Polymer Market by type (Medical plastics, Medical elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global...

at 06:00
Capsida Biotherapeutics to Present Preclinical Data for Parkinson's Disease Associated with GBA Mutations Showing High Levels of GCase Enzyme Supplementation Following IV Administration
Next-generation gene therapy demonstrates best-in-class potential with majority of neurons transduced in substantia nigra and high levels of GCase supplementation after single IV infusion Broad GCase elevation achieved in NHPs, while significantly...

at 06:00
Celebrate Women During Women's Health Week with Women's Excellence
As we head into Women's Health Week, Women's Excellence is proud to reaffirm its dedication to the well-being and empowerment of women across Metro Detroit. From May 12th to May 18th, our practice joins the nationwide effort to highlight the...

at 06:00
Affinia Therapeutics Presents Preclinical Data for Genetic Cardiomyopathy and Sporadic ALS Programs with Novel Cardiotropic and BBB-Penetrant AAV Capsids at the American Society of Gene & Cell Therapy 2024 Annual Meeting
...

at 05:45
Investors in QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact The Gross Law Firm Before June 11, 2024 to Discuss Your Rights - QDEL
The Gross Law Firm issues the following notice to shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation . Shareholders who...

More news about Health...


News published on and distributed by: